Chinmay Jani, Chief Fellow of Hematology and Oncology at Sylvester Comprehensive Cancer Center at the University of Miami, shared a post on X:
“t was a privilege to moderate ‘The Business of Precision Oncology: Innovation, Impact, and Implementation’ at Healthcar eBusiness Conference26 at Johns Hopkins Carey Business School.
Key insights:
- De-risking drug development through biomarker-driven precision oncology – Dr. William Nelson, Johns Hopkins Kimmel Cancer Center
- Precision medicine enabling more effective immunotherapy & cellular therapy delivery – Dr David Ryan, MassGeneral News
- Federal + philanthropic funding critical for research infrastructure – Thomas George, UF Health Cancer Institute
- AI is an essential step in the future of cancer care – Stephen D. Nimer.“
Other articles featuring Chinmay Jani on OncoDaily.